Author | Nancy Lin, MD | OncLive

Author | Nancy Lin, MD


Dr. Lin on the Treatment Landscape in HER2+ Metastatic Breast Cancer

July 16, 2020


Nancy U. Lin, MD, discusses the treatment landscape in HER2-positive metastatic breast cancer. 

Dr. Lin on CNS-Specific Outcomes With Neratinib in HER2+ Breast Cancer

February 12, 2020


Nancy Lin, MD, discusses central nervous system–specific outcomes with neratinib (Nerlyx) in HER2-positive breast cancer.

Dr. Lin on Impact of Neratinib on CNS Metastases in HER2+ Breast Cancer

December 13, 2019


Nancy Lin, MD, discusses the impact of neratinib on development and progression of central nervous system metastases in patients with HER2-positive metastatic breast cancer.